Immunocore Holdings plc (FRA:6YG)
Germany · Delayed Price · Currency is EUR 24.00
-1.00 (-4.00%)
Last updated: Jun 3, 2026, 7:55 PM CET
Immunocore Holdings Employees
Immunocore Holdings had 524 employees as of December 31, 2025. The number of employees increased by 31 or 6.29% compared to the previous year.
Employees
524
Change (1Y)
31
Growth (1Y)
6.29%
Revenue / Employee
€683,267
Profits / Employee
€45,626
Market Cap
1.29B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 524 | 31 | 6.29% |
| Dec 31, 2024 | 493 | -4 | -0.80% |
| Dec 31, 2023 | 497 | 89 | 21.81% |
| Dec 31, 2022 | 408 | 84 | 25.93% |
| Dec 31, 2021 | 324 | 33 | 11.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Immunocore Holdings News
- 2 days ago - Immunocore presents updated results from Phase 1/2 trial of brenetafusp - TheFly
- 3 days ago - Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma - GlobeNewsWire
- 21 days ago - Immunocore Holdings Slides: Corporate presentation - Filings
- 4 weeks ago - Immunocore reports first quarter financial results and provides a business update - GlobeNewsWire
- 4 weeks ago - Immunocore Holdings Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Immunocore Holdings Earnings release: Q1 2026 - Filings
- 6 weeks ago - Immunocore announces five-year overall survival data for Kimmtrak - TheFly
- 6 weeks ago - KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma - GlobeNewsWire